You just read:

MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund

News provided by

MabVax Therapeutics, Inc.

Nov 20, 2012, 07:00 ET